Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 3
2006 2
2007 1
2008 6
2009 5
2010 5
2011 5
2012 3
2013 8
2014 6
2015 7
2016 5
2017 9
2018 6
2019 7
2020 11
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
New Insights on KCa3.1 Channel Modulation.
Manfroni G, Ragonese F, Monarca L, Astolfi A, Mancinelli L, Iannitti RG, Bastioli F, Barreca ML, Cecchetti V, Fioretti B. Manfroni G, et al. Among authors: cecchetti v. Curr Pharm Des. 2020;26(18):2096-2101. doi: 10.2174/1381612826666200316152645. Curr Pharm Des. 2020. PMID: 32175839
Pharmacological Agents Targeting the Cellular Prion Protein.
Barreca ML, Iraci N, Biggi S, Cecchetti V, Biasini E. Barreca ML, et al. Among authors: cecchetti v. Pathogens. 2018 Mar 7;7(1):27. doi: 10.3390/pathogens7010027. Pathogens. 2018. PMID: 29518975 Free PMC article. Review.
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.
Cannalire R, Tarantino D, Piorkowski G, Carletti T, Massari S, Felicetti T, Barreca ML, Sabatini S, Tabarrini O, Marcello A, Milani M, Cecchetti V, Mastrangelo E, Manfroni G, Querat G. Cannalire R, et al. Among authors: cecchetti v. Antiviral Res. 2019 Jul;167:6-12. doi: 10.1016/j.antiviral.2019.03.004. Epub 2019 Mar 6. Antiviral Res. 2019. PMID: 30849420
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents.
Felicetti T, Burali MS, Gwee CP, Ki Chan KW, Alonso S, Massari S, Sabatini S, Tabarrini O, Barreca ML, Cecchetti V, Vasudevan SG, Manfroni G. Felicetti T, et al. Among authors: cecchetti v. Eur J Med Chem. 2021 Jan 15;210:112992. doi: 10.1016/j.ejmech.2020.112992. Epub 2020 Nov 4. Eur J Med Chem. 2021. PMID: 33208235
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors.
Nizi MG, Desantis J, Nakatani Y, Massari S, Mazzarella MA, Shetye G, Sabatini S, Barreca ML, Manfroni G, Felicetti T, Rushton-Green R, Hards K, Latacz G, Satała G, Bojarski AJ, Cecchetti V, Kolář MH, Handzlik J, Cook GM, Franzblau SG, Tabarrini O. Nizi MG, et al. Among authors: cecchetti v. Eur J Med Chem. 2020 Sep 1;201:112420. doi: 10.1016/j.ejmech.2020.112420. Epub 2020 Jun 5. Eur J Med Chem. 2020. PMID: 32526553
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.
Massari S, Corona A, Distinto S, Desantis J, Caredda A, Sabatini S, Manfroni G, Felicetti T, Cecchetti V, Pannecouque C, Maccioni E, Tramontano E, Tabarrini O. Massari S, et al. Among authors: cecchetti v. J Enzyme Inhib Med Chem. 2019 Dec;34(1):55-74. doi: 10.1080/14756366.2018.1523901. J Enzyme Inhib Med Chem. 2019. PMID: 30362381 Free PMC article.
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page